Aileron Therapeutics, Inc.ALRNNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank75
3Y CAGR+5.7%
5Y CAGR+4.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+5.7%/yr
vs -7.9%/yr prior
5Y CAGR
+4.1%/yr
Consistent
Acceleration
+13.6pp
Accelerating
Percentile
P75
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $11.42M | -17.6% |
| 2024 | $13.86M | +22.1% |
| 2023 | $11.36M | +17.3% |
| 2022 | $9.68M | +0.9% |
| 2021 | $9.60M | +2.9% |
| 2020 | $9.33M | -24.1% |
| 2019 | $12.29M | -8.6% |
| 2018 | $13.45M | +53.4% |
| 2017 | $8.77M | +11.1% |
| 2016 | $7.89M | - |